Cyclins D1 and D2 mediate Myc-induced proliferation via sequestration of p27(Kip1) and p21(Cip1)

EMBO Journal

Volumn 18, Issue 19, 1999, Pages 5310-5320

  Perez Roger, Ignacio ^a,b   Kim, Soo Hyun ^a   Griffiths, Beatrice ^a   Sewing, Andreas ^a,c   Land, Hartmut ^a,d  

^a IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^b INSTITUTO DE BIOMEDICINA DE VALENCIA   (Spain)

^c GLAXOSMITHKLINE   (United Kingdom)

^d UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

Cyclin D; Cyclin E; Myc; p21(Cip1); p27(Kip1)

Indexed keywords

CYCLIN D1; CYCLIN D2; CYCLIN DEPENDENT KINASE; CYCLIN E; MESSENGER RNA; PHOSPHOTRANSFERASE; PROTEIN P21; PROTEIN P27;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL CYCLE G1 PHASE; CELL DEATH; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVATION; MOUSE; NONHUMAN; ONCOGENE MYC; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; RAT; RETROVIRUS;

3T3 CELLS; ANIMALS; APOPTOSIS; BASE SEQUENCE; CDC2-CDC28 KINASES; CELL CYCLE PROTEINS; CELL DIVISION; CELL LINE; CYCLIN D1; CYCLIN E; CYCLIN-DEPENDENT KINASE 2; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLIN-DEPENDENT KINASE INHIBITOR P27; CYCLIN-DEPENDENT KINASES; CYCLINS; DNA PRIMERS; ENZYME ACTIVATION; MICE; MICROTUBULE-ASSOCIATED PROTEINS; PROTEIN BINDING; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS C-MYC; RATS; TUMOR SUPPRESSOR PROTEINS;

ANIMALIA; UNIDENTIFIED RETROVIRUS;

EID: 0033214995     PISSN: 02614189     EISSN: None     Source Type: Journal    
DOI: 10.1093/emboj/18.19.5310     Document Type: Article

References (71)

1. Kipl. EMBO J., 17, 5987-5997.
2. Amati, B., Dalton, S., Brooks, M.W., Littlewood, T.D., Evan, G.I. and Land, H. (1992) Transcriptional activation by the human c-Myc oncoprotein in yeast requires interaction with Max. Nature, 359, 423-426.
3. Amati, B., Brooks, M.W., Levy, N., Littlewood, T.D., Evan, G.I. and Land, H. (1993a) Oncogenic activity of the c-Myc protein requires dimerization with Max. Cell. 72, 233-245.
4. Amati, B., Littlewood, T.D., Evan, G.I. and Land, H. (1993b) The c-Myc protein induces cell cycle progression and apoptosis through dimerization with Max. EMBO J., 12, 5083-5087.
5. Amati, B., Alevizopoulos, K. and Vlach, J. (1998) Myc and the cell cycle. Front. Biosci., 3, D250-268.
6. 1. Genes Dev., 7, 812-821.
7. Barone, M.V. and Courtneidge, S.A. (1995) Myc but not Fos rescue of PDGF signalling block caused by kinase-inactive Src. Nature, 378, 509-512.
8. 1 arrest through reduction of cyclin E-CDK2 kinase activity. Oncogene. 15, 1347-1356.
9. Blackwell, T.K., Kretzner, L., Blackwood, E.M., Eisenman, R.N. and Weintraub, H. (1990) Sequence-specific DNA binding by the c-Myc protein. Science, 250, 1149-1151.
10. Blackwood, E.M. and Eisenman, R.N. (1991) Max: a helix-loop-helix zipper protein that forms a sequence-specific DNA-binding complex with Myc. Science, 251, 1211-1217.
11. Bouchard, C. et al. (1999) Direct induction of cyclin D2 by Myc contributes to cell cycle progression and sequestration of p27. EMBO J., 18, 5321-5333.
12. Braselmann, S., Graninger, P. and Busslinger, M. (1993) A selective transcriptional induction system for mammalian cells based on Ga14-estrogen receptor fusion proteins. Proc. Natl Acad. Sci. USA, 90, 1657-1661.
13. Bush, A., Mateyak, M., Dugan, K., Obaya, A., Adachi, S., Sedivy, J. and Cole, M. (1998) c-myc null cells misregulate cad and gadd45 but not other proposed c-Myc targets. Genes Dev., 12, 3797-37802.
14. Kipl CDK 'inhibitors' are essential activators of cyclin D-dependent kinases in marine fibroblasts. EMBO J., 18, 1571-1583.
15. Dang, C.V. (1999) c-Myc target genes involved in cell growth, apoptosis and metabolism. Mol. Cell. Biol., 19, 1-11.
16. Diehl, J.A. and Sherr, C.J. (1997) A dominant-negative cyclin D1 mutant prevents nuclear import of cyclin-dependent kinase 4 (CDK4) and its phosphorylation by CDK-activating kinase. Mol. Cell. Biol., 17, 7362-7374.
17. 1 cyclins. Curr. Opin. Cell Biol., 6, 842-846.
18. Eilers, M., Schirm, S. and Bishop, J.M. (1991) The MYC protein activates transcription of the α-prothymosin gene. EMBO J., 10, 133-141.
19. Evan, G., Lewis, G., Ramsay, G. and Bishop, J. (1985) Isolation of monoclonal antibodies specific for the human c-myc protooncogene product. Mol. Cell. Biol., 5, 3610-3616.
20. Evan, G.I., Wyllie, A.H., Gilbert, C.S., Littlewood, T.D., Land, H., Brooks, M., Waters, C.M., Penn, L.Z. and Hancock, D.C. (1992) Induction of apoptosis in Fibroblasts by c-Myc protein. Cell, 69, 119-128.
21. Fantl, V., Stamp, G., Andrews, A., Rosewell, I. and Dickson, C. (1995) Mice lacking cyclin D1 are small and show defects in eye and mammary gland development. Genes Dev., 9, 2364-2372.
22. Kipl. Oncogene, 13, 2447-2457.
23. INK4B is a potential effector of TGF-β-induced cell cycle arrest. Nature, 371, 257-261.
24. Harrington, E.A., Bennett, M.R., Fanidi, A. and Evan, G.I. (1994) c-Myc-induced apoptosis in fibroblasts is inhibited by specific cytokines. EMBO J., 13, 3286-3295.
25. Henriksson, M. and Lüscher, B. (1996) Proteins of the Myc network: essential regulators of cell growth and differentiation. Adv. Cancer Res., 68, 109-182.
26. INK4a-mediated growth suppression. Mol. Cell. Biol., 18, 5284-5290.
27. Kelly, K. and Siebenlist, U. (1986) The regulation and expression of c-myc in normal and malignant cells. Annu. Rev. Immunol., 4, 317-338.
28. Knoblich, J.A., Sauer, K., Jones, L., Richardson, H., Saint, R. and Lehner, C.F. (1994) Cyclin E controls S phase progression and its down-regulation during Drusophila embryogenesis is required for the arrest of cell proliferation. Cell, 77, 107-120.
29. Kretzner, L., Blackwood, E.M. and Eisenman, R.N. (1992) Myc and Max proteins possess distinct transcriptional activities. Nature, 359, 426-429.
30. LaBaer, J., Garrett, M.D., Stevenson, L.F., Slingerland, J.M., Sandhu, C., Chou, H.S., Fattaey, A. and Harlow, E. (1997) New functional activities for the p21 family of CDK inhibitors. Genes Dev., 11, 847-862.
31. Land, H. (1995) Transformation of primary rat embryo cells. Methods Enzymol., 254, 37-41.
32. Littlewood, T.D., Hancock, D.C., Danielian, P.S., Parker, M.G. and Evan, G.I. (1995) A modified oestrogen receptor ligand-binding domain as an improved switch for the regulation of heterologous proteins. Nucleic Acids Res., 23, 1686-1690.
33. Marcu, K.B., Bossone, S.A. and Patel, A.J. (1992) myc function and regulation. Annu. Rev. Biochem., 61, 809-860.
34. Mateyak, M.K., Obaya, A.J., Adachi, S. and Sedivy, J.M. (1997) Phenotypes of c-Myc-deficient rat fibroblasts isolated by targeted homologous recombination. Cell Growth Differ., 8, 1039-1048.
35. INK4a inhibits both CDK4- and CDK2-associated kinase activity by reassortment of cyclin-CDK-inhibitor complexes. Mol. Cell. Biol., 19, 1981-1989.
36. McMahon, S.B., Van, B.H., Dugan, K.A., Copeland, T.D. and Cole, M.D. (1998) The novel ATM-related protein TRRAP is an essential cofactor for the c-Myc and E2F oncoproteins. Cell, 94, 363-374.
37. Morgan, D.O. (1995) Principles of CDK regulation. Nature, 374, 131-134.
38. Morgenstern, J.P. and Land, H. (1990) Advanced mammalian gene transfer: high titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line. Nucleic Acids Res., 18, 3587-3596.
39. Mougneau, E., Lemieux, L., Rassoulzadegan, M. and Cuzin, F. (1984) Biological activities of v-myc and rearranged c-myc oncogenes in rat fibroblast cells in culture. Proc. Natl Acad. Sci. USA, 81, 5758-5762.
40. Muller, D., Bouchard, C., Rudolph, B., Steiner, P., Stuckmann, I., Saffrich, R., Ansorge, W., Huttner, W. and Eilers, M. (1997) Cdk2-dependent phosphorylation of p27 facilitates its Myc-induced release from cyclin E/cdk2 complexes. Oncogene, 15, 2561-2576.
41. 1 in mammalian fibroblasts. Science, 259, 1908-1912.
42. 1-to-S phase transition. Mol. Cell. Biol., 15, 2612-2624.
43. Pear, W.S., Nolan, G.P., Scott, M.L. and Baltimore, D. (1993) Production of high-titer helper-free retroviruses by transient transfection. Proc. Natl Acad. Sci. USA, 90, 8392-8396.
44. Kipl binding to newly formed complexes. Oncogene, 14, 2373-2381.
45. Planas-Silva, M. and Weinberg, R.A. (1997) Estrogen-dependent cyclin E-cdk2 activation through p21 redistribution. Mol. Cell. Biol., 17, 4059-4069.
46. Kipl, a cyclin-Cdk inhibitor, links transforming growth factor-β and contact inhibition to cell cycle arrest. Genes Dev., 8, 9-22.
47. Poon, R.Y., Toyoshima, H. and Hunter, T. (1995) Redistribution of the CDK inhibitor p27 between different cyclin. CDK complexes in the mouse fibroblast cell cycle and in cells arrested with lovastatin or ultraviolet irradiation. Mol. Biol. Cell, 6, 1197-1213.
48. Prendergast, G.C. and Ziff, E.B. (1991) Methylation-sensitive sequence-specific DNA binding by the c-Myc basic region. Science, 251, 186-189.
49. Prendergast, G.C., Lawe, D. and Ziff, E.B. (1991) Association of Myn, the murine homolog of max, with c-Myc stimulates methylation-sensitive DNA binding and ras cotransformation. Cell, 65, 395-407.
50. 1-cyclin-dependent kinases. Oncogene, 15, 649-656.
51. 1 phase in rodent fibroblasts. Genes Dev., 7, 1559-1571.
52. 1/S phase transition by expression of cyclins D1 and E with an inducible system. Mol. Cell. Biol., 14, 1669-1679.
53. Kipl coordinate their inhibitory interactions with cdk4 and cdk2. Genes Dev., 11, 492-503.
54. Reynisdottir, I., Polyak, K., Iavarone, A. and Massague, J. (1995) Kip-Cip and Ink4 Cdk inhibitors cooperate to induce cell cycle arrest in response to TGF-β. Genes Dev., 9, 1831-1845.
55. Roussel, M.F., Cleveland, J.L., Shurtleff, S.A. and Sherr, C.J. (1991) Myc rescue of a mutant CSF-1 receptor impaired in mitogenic signalling. Nature, 353, 361-363.
56. Rudolph, B., Saffrich, R., Zwicker, J., Henglein, B., Muller, R., Ansorge, W. and Eilers, M. (1996) Activation of cyclin-dependent kinases by Myc mediates induction of cyclin A, but not apoptosis. EMBO J., 15, 3065-3076.
57. Saleh, A., Schieltz, D., Ting, N., McMahon, S.B., Litchfield, D.W., Yates, J.R.,III, Lees-Miller, S.P., Cole, M.D. and Brandl, C.J. (1998) Tra1p is a component of the yeast Ada. Spt transcriptional regulatory complexes. J. Biol. Chem., 273, 26559-26565.
58. Cipl. Mol. Cell. Biol., 17, 5588-5597.
59. Kipl. Genes Dev., 11, 1464-1478.
60. 1 phase progression: cycling on cue. Cell, 79, 551-555.
61. 1 cyclin-dependent kinases. Genes Dev., 9, 1149-1163.
62. Sicinski, P. et al. (1996) Cyclin D2 is an FSH-responsive gene involved in gonadal cell proliferation and oncogenesis. Nature, 384, 470-474.
63. Solomon, D.L., Philipp, A., Land, H. and Eilers, M. (1995) Expression of cyclin D1 mRNA is not upregulated by Myc in rat fibroblasts. Oncogene, 11, 1893-1897.
64. Soos, T.J. et al. (1996) Formation of p27-CDK complexes during the human mitotic cell cycle. Cell Growth Differ., 7, 135-146.
65. 1 cyclin-cdk complexes. EMBO J.,., 14, 4814-4826.
66. 1 cyclin-Cdk protein kinase activity, is related to p21. Cell, 78, 67-74.
67. Kipl is abrogated by c-myc. EMBO J., 15, 6595-6604.
68. Vlach, J., Hennecke, S. and Amati, B. (1997) Phosphorylation-dependent degradation of the cyclin-dependent kinase inhibitor p27. EMBO J., 16, 5334-5344.
69. 1 progression through tetracycline-regulated expression of human cyclin E. Oncogene, 9, 995-997.
70. Xiao, Q., Claassen, G., Shi, J., Adachi, S., Sedivy, J. and Hann, S.R. (1998) Transactivation-defective c-MycS retains the ability to regulate proliferation and apoptosis. Genes Dev., 12, 3803-3808.
71. Zindy, F., Eischen, C.M., Randle, D.H., Kamijo, T., Cleveland, J.L., Sherr, C.J. and Roussel, M.F. (1998) Myc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalization. Genes Dev., 12, 2424-2433.